Ruth A Karron Selected Research

Antigen-Antibody Complex (Immune Complex)

1/2007

C5 modulates airway hyperreactivity and pulmonary eosinophilia during enhanced respiratory syncytial virus disease by decreasing C3a receptor expression.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ruth A Karron Research Topics

Disease

11	Pneumonia (Pneumonitis) 11/2023 - 01/2007
10	Paramyxoviridae Infections (Parainfluenza) 12/2015 - 05/2003
8	Human Influenza (Influenza) 01/2023 - 11/2010
7	Infections 11/2023 - 05/2002
7	Respiratory Syncytial Virus Infections 07/2023 - 12/2004
6	Respiratory Sounds (Crackle) 11/2020 - 06/2004
5	COVID-19 08/2023 - 01/2022
3	Fever (Fevers) 11/2018 - 06/2013
3	Respiratory Tract Infections (Respiratory Tract Infection) 02/2016 - 08/2002
2	Rhinorrhea 07/2023 - 06/2004
2	Communicable Diseases (Infectious Diseases) 11/2022 - 10/2018
2	Malaria 01/2019 - 02/2016
2	Hypergammaglobulinemia (Hyperimmunoglobulinemia) 01/2019 - 02/2016
1	Respiratory Tract Diseases (Respiratory Tract Disease) 11/2023
1	Emerging Communicable Diseases (Emerging Infectious Diseases) 01/2021
1	Asthma (Bronchial Asthma) 01/2020
1	HIV Infections (HIV Infection) 01/2019
1	Premature Birth (Birth, Premature) 01/2019
1	Bacterial Pneumonia 06/2017
1	Pneumococcal Pneumonia 06/2017
1	Tachypnea 12/2016
1	Tachycardia (Tachyarrhythmias) 12/2016
1	Hypersensitivity (Allergy) 12/2015
1	Influenza in Birds (Avian Flu) 06/2009
1	Eosinophilia 01/2007
1	Pulmonary Eosinophilia (Eosinophilic Pneumonia) 01/2007
1	Inflammation (Inflammations) 06/2005
1	Cough 06/2004

Drug/Important Bio-Agent (IBA)

30	VaccinesIBA 08/2023 - 05/2003
7	Respiratory Syncytial Virus VaccinesIBA 11/2023 - 12/2004
5	Anti-Bacterial Agents (Antibiotics)IBA 11/2023 - 04/2012
4	Neutralizing AntibodiesIBA 07/2023 - 10/2008
4	Influenza Vaccines (Influenza Vaccine)FDA Link 10/2017 - 06/2009
2	AntibodiesIBA 01/2023 - 05/2002
2	Monoclonal AntibodiesIBA 01/2020 - 12/2015
2	Immunoglobulin G (IgG)IBA 01/2019 - 10/2008
2	C-Reactive ProteinIBA 06/2017 - 06/2017
2	motavizumab (Numax)IBA 12/2016 - 12/2015
2	Glycoproteins (Glycoprotein)IBA 10/2008 - 06/2005
2	GTP-Binding Proteins (G-Protein)IBA 12/2004 - 05/2002
1	InterferonsIBA 07/2023
1	MicronutrientsIBA 01/2023
1	ArsenicIBA 01/2023
1	Coloring Agents (Dyes)IBA 06/2017
1	N-Acetylmuramoyl-L-alanine Amidase (Autolysin)IBA 06/2017
1	DNA (Deoxyribonucleic Acid)IBA 06/2017
1	ORALIT (ORS)IBA 12/2016
1	Immunoglobulins (Immunoglobulin)IBA 02/2016
1	Membrane Glycoproteins (Membrane Glycoprotein)IBA 01/2013
1	Complement System Proteins (Complement)IBA 01/2007
1	Antigen-Antibody Complex (Immune Complex)IBA 01/2007
1	CytokinesIBA 06/2004
1	Attenuated VaccinesIBA 02/2004
1	EnzymesIBA 08/2002
1	Amino Acids FDA Link 05/2002
1	AA 193IBA 05/2002

Therapy/Procedure

1	Transcutaneous Electric Nerve Stimulation (TENS) 11/2023
1	Stethoscopes 11/2020
1	Contraindications 08/2016
1	Therapeutics 04/2012